Latest Breaking News On - Synthetic control arm - Page 1 : comparemela.com

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update

Arcus and Gilead announced an additional equity investment of $320 million into Arcus and modifications to their domvanalimab + zimberelimab clinical program to focus on the highest unmet medical.

Terry rosenJohanna mercierDevelopment rd expensesExchange commission onExchange commissionCompany annual report on formArcus biosciences incArcus biosciencesChief commercial officerDomvanalimab zimberelimab milestonesSafety dataOverall survivalSynthetic control armFourth quarterFull yearCash equivalents

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update

HAYWARD, Calif. (BUSINESS WIRE) Feb 21, 2024

United statesJohanna mercierTerry rosenHolli kolkeyDevelopment rd expensesCorporate communicationsArcus biosciences incExchange commission onCompany annual report on formExchange commissionChief commercial officerDomvanalimab zimberelimab milestonesSafety dataOverall survivalSynthetic control armFourth quarter

Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer

HAYWARD, Calif. (BUSINESS WIRE) Jan 16, 2024

University of california los angelesUnited statesHolli kolkeyZeva wainbergExchange commissionArcus biosciences incCorporate communicationsGilead sciencesCalifornia los angelesDassault systSynthetic control armAll pooledHistorical controlArcus biosciencePrivate securities litigation reform actQuarterly report

Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer

Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesHolli kolkeyZeva wainbergExchange commissionArcus biosciences incGilead sciencesCorporate communicationsMedian overall survivalSynthetic control armCancers symposiumCalifornia los angelesDassault systAll pooledHistorical controlArcus biosciencePrivate securities litigation reform act

Arcus Biosciences (RCUS) Reports Data from a Phase 1b Study of Quemliclustat-Based Regimens Showing Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer

Arcus Biosciences (RCUS) Reports Data from a Phase 1b Study of Quemliclustat-Based Regimens Showing Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesZeva wainbergArcus biosciences incGilead sciencesArcus biosciencesCalifornia los angelesDassault systSynthetic control armAll pooledHistorical control